Genetics and Immunology Reproductive Immunology

Exploring the Immunological Aspects and Treatments of Recurrent Pregnancy Loss and Recurrent Implantation Failure

Garmendia JV, De Sanctis CV, Hajdúch M, De Sanctis JB

Published February 3, 2025 International journal of molecular sciences, 26(3)
DOI 10.3390/ijms26031295 PMID 39941063 PMC PMC11818386

RRM Academy Synopsis

Immune cell differences are linked to recurrent miscarriage

A 2025 narrative review of repeated miscarriage and repeated failed embryo transfer reports that immune cells and signaling molecules differ in affected women. Immune drugs gave mixed results. Almost half of women with repeated loss have no known cause.

Key Findings

  • About 3–5% of women who are trying to conceive experience recurrent pregnancy loss. Almost 50% of women with RPL have no known cause.
  • NK cells in peripheral blood were significantly higher in women with RPL than in controls. One meta-analysis found no significant difference in uterine NK cells.
  • Sharing HLA genes at 3 or more loci between partners was associated with RIF.
  • In the ALIFE2 trial, 326 women with RPL and an inherited clotting disorder had live births at rates of 72% vs 71% with heparin and without it.
  • In a placebo-controlled trial of patients with four or more RPL and unknown risk factors, 58.0% had a live birth with IVIG and 34.7% with placebo.

Interpretation

The paper is a narrative review that gathers observational studies, trials and meta-analyses. Many immune findings are associations between a cell pattern and a pregnancy outcome, and several studies disagree. The authors write that the varied approaches make results hard to interpret. The review says one society backs heparin and aspirin only for antiphospholipid syndrome and names no treatment for other cases of repeated loss.

RRM Context

The review lists hormone, uterine, thyroid, infection and metabolic causes beside immune ones, along with male factor. Repeated loss with no known cause is undiagnosed, so restorative reproductive medicine looks for causes in both partners. The authors say patients should be better classified by immune and hormone factors.

Abstract

Recurrent pregnancy loss (RPL) is defined as the occurrence of two or more consecutive pregnancy losses before 24 weeks of gestation. It affects 3-5% of women who are attempting to conceive. RPL can stem from a variety of causes and is frequently associated with psychological distress and a diminished quality of life. By contrast, recurrent implantation failure (RIF) refers to the inability to achieve a successful pregnancy after three or more high-quality embryo transfers or at least two instances of egg donation. RIF shares several causative factors with RPL. The immunological underpinnings of these conditions involve alterations in uterine NK cells, reductions in M2 macrophages and myeloid-derived suppressor cells, an increased Th1/Th2 ratio, a decreased Treg/Th17 ratio, the presence of shared ≥3 HLA alleles between partners, and autoimmune disorders. Various therapeutic approaches have been employed to address these immunological concerns, achieving varying degrees of success, although some therapies remain contentious within the medical community. This review intends to explore the immunological factors implicated in RPL and RIF and to analyze the immunological treatments employed for these conditions, which may include steroids, intravenous immunoglobulins, calcineurin inhibitors, anti-TNF antibodies, intralipid infusions, granulocyte colony-stimulating factor, and lymphocyte immunotherapy.

Read the guide

  • Miscarriage and Recurrent Pregnancy Loss: The Workup Most Women Never Get

    Miscarriage affects approximately 15% of clinically confirmed pregnancies. Recurrent pregnancy loss (RPL), defined as two or more clinical losses, affects 2 to 5% of couples. Most causes are diagnosable and treatable. This guide covers what the standard workup misses, what RRM-trained clinicians evaluate, and what outcomes look like after cause-based treatment.

    22 min read

Topics

Related research

Genetics and Immunology › Reproductive Immunology › Implantation Immunology · Infertility › Recurrent Pregnancy Loss › Immune and Thrombophilia Factors · Pregnancy › Pregnancy Complications › Intrauterine Infection
Jenny Valentina Garmendia, Claudia Valentina De Sanctis, Marián Hajdúch, Juan Bautista De Sanctis
Jennifer Garmendia, J Garmendia, C Sanctis, M Hajdúch, J Sanctis
PMID 39941063 39941063 DOI 10.3390/ijms26031295 10.3390/ijms26031295 Garmendia et al. 2025, Garmendia 2025